Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/12623
Title: Two-year safety and tolerability study of enfuvertide use in salvage therapy of Thai HIV-1 experienced cases
Authors: Wisit Prasithsirikul
Mattana Hanvanich
Surapol Suwanagool
Winai Ratanasuwan
Thanomsak Anekthananon
Wichai Techasathit
Khuanchai Supparatpinyo
Asda Viphagool
Thailand Ministry of Public Health
Chulalongkorn University
Mahidol University
Chiang Mai University
Bamrungrad International Hospital
Keywords: Medicine
Issue Date: 1-Mar-2011
Citation: Journal of the Medical Association of Thailand. Vol.94, No.3 (2011), 303-308
Abstract: Objective: To assess safety and tolerability of enfuvirtide, an antiretroviral, in Thai patients with advanced HIV-1 disease who have received antiretroviral treatment and failed on regimens that contain at least one of each antiretroviral (ARV) classes (PIs, NRTIs, and NNRTIs), or who have intolerance to previous antiretroviral regimens. Material and Method: An open-label non-comparative study of enfuvirtide used in salvage regimens along with the backbone antiretroviral therapy of choice in Thai HIV-1 experienced cases that have been treated with at least one of each available ARV classes. Results: Twenty-three patients were recruited from five participating centers. Seventeen patients (74%) completed 96 weeks of the treatment. Six patients prematurely withdrew from the present study in which three expired from HIV related complications, two withdrew consents, and one from adverse event. The most common adverse event is injection site reactions, which occurred in 22 patients. The manifestations and intensity varied from rash, erythema, edema, pain, induration, and bleeding at the injection sites, to inflammatory nodules. Most of the patients tolerated the treatment well. Enfuvirtide administered along with other antiretroviral combination provided a good control of the disease. Conclusion: Enfuvirtide was well tolerated by Thai patients who participated in the present study. The adverse events did not compromise the patient compliance.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79953692427&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/12623
ISSN: 01252208
01252208
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.